Systemic inflammation and mortality in chronic obstructive pulmonary disease

By Sin Don D.   Man S.F. P.  

Canadian Journal of Physiology and Pharmacology, Vol. 85, Iss. 1, 2007-01 ,pp. : 141-147

NRC Research Press

Access to resources Recommend Favorite

Approaches to Gradual Dose Reduction of Chronic Off-Label Antipsychotics Used for Behavioral and Psychological Symptoms of Dementia

By Tjia Jennifer   Reidenberg Marcus M.   Hunnicutt Jacob N.   Paice Kelli   Donovan Jennifer L.   Kanaan Abir   Briesacher Becky A.   Lapane Kate L.  

The Consultant Pharmacist, Vol. 30, Iss. 10, 2015-10 ,pp. : 599-611

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Hospitalizations for chronic obstructive pulmonary disease exacerbations and their impact on disease and subsequent morbidity and mortality

By Antoniu Sabina Antonela   Carone Mauro  

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 13, Iss. 2, 2013-04 ,pp. : 187-189

Informa Healthcare

Access to resources Recommend Favorite

ISCHEMIC HEART DISEASE MORTALITY REDUCTION IN AN ARSENIASIS-ENDEMIC AREA IN SOUTHWESTERN TAIWAN AFTER A SWITCH IN THE TAP-WATER SUPPLY SYSTEM

By Chang Chih-Ching   Ho Shu-Chen   Tsai Shang-Shyue   Yang Chun-Yuh  

Journal of Toxicology and Environmental Health, Vol. 67, Iss. 17, 2004-09 ,pp. : 1353-1361

Taylor & Francis Ltd

Access to resources Recommend Favorite

Use of statins reduces the risk of mortality for patients with an acute exacerbation of chronic obstructive pulmonary disease

By  

Inpharma, Vol. 1, Iss. 1580, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite